Executive Director, US Healthcare Compliance

Responsibilities: Build and strengthen Cytokinetics’ culture of business integrity and compliance with senior leadership. Drive Cytokinetics’ U.S. healthcare compliance program consistent with OIG Compliance Program Guidance for Pharmaceutical Manufacturers; collaborate with legal, finance, and operations to develop, maintain, and continuously improve the program, including clear policies, live/online training, and data-driven monitoring. Lead the brand compliance strategy for the MYQORZO (aficamten) commercial lifecycle, including compliance operations for product promotion, unbranded cardiovascular health programs, medical affairs, and market access. Chair the Global Healthcare Compliance Committee, overseeing cross-functional interactions with HCPs and HCOs; identify, manage, and report global operational risks to executive management and the Board. Qualifications: 15+ years as a compliance professional in the U.S. (in-house at a biopharmaceutical company, at a major law firm serving biopharmaceutical clients, or both). Relevant graduate education (JD or other advanced degree strongly preferred). Deep familiarity with U.S. federal/state laws and self-regulatory codes for pharmaceutical development/commercialization, including Anti-Kickback Statute, False Claims Act, Physician Payment Sunshine Act, and PhRMA Code. Proven success chairing high-level committees and influencing executive-level stakeholders in a fast-paced, matrixed environment. Pay Range & Total Rewards: Expected salary range (South San Francisco, CA): $337,500–$393,800; plus competitive total compensation including equity (stock options/RSUs), health/dental/vision/life/disability insurance, 401(k) match, learning/wellness stipends, and paid time off. #J-18808-Ljbffr Scorpion Therapeutics